Robert Kristal - Feb 17, 2023 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role: Chief Financial Officer
Signature: /s/ Robert Kristal
Stock symbol: BRTX
Transactions as of: Feb 17, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/17/2023, 04:32 PM
Previous filing: Nov 4, 2022
Next filing: Feb 15, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BRTX	Common Stock						7.99K	Feb 17, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BRTX	Stock Option	Award	$0	+89K		$0.00	89K	Feb 17, 2023	Common Stock	89K	$2.91	Direct	F2
holding	BRTX	Stock Option						10.5K	Feb 17, 2023	Common Stock	10.5K	$5.08	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.
F2	The option vests and becomes exercisable to the extent of 44,484 shares on February 17, 2023 with the remaining 44,484 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested.